Feng Chi Biotech Corp. (TPEX:6744)
Taiwan · Delayed Price · Currency is TWD 15.90
+0.40 (2.58%)
At close: Jun 12, 2026
Feng Chi Biotech Market Cap
Feng Chi Biotech has a market cap or net worth of 244.86 million as of June 12, 2026. Its market cap has decreased by -24.29% in one year.
Market Cap
244.86M
Enterprise Value
72.16M
Revenue
177.36M
Ranking
n/a
PE Ratio
16.92
Stock Price
15.90
Market Cap Chart
Since September 25, 2019, Feng Chi Biotech's market cap has decreased from 742.28M to 244.86M, a decrease of -67.01%. That is a compound annual growth rate of -15.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 244.86M | -10.67% |
| Dec 31, 2025 | 274.12M | -10.10% |
| Dec 30, 2024 | 304.92M | -10.81% |
| Dec 29, 2023 | 341.88M | 11.00% |
| Dec 29, 2022 | 308.00M | -19.19% |
| Dec 28, 2021 | 381.15M | -16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NatureWise Biotech & Medicals | 850.75M |
| Neith | 791.43M |
| MegaPro Biomedical | 776.65M |
| BioLASCO Taiwan | 773.48M |
| SynCore Biotechnology Co.,Ltd | 741.97M |
| TaiwanJ Pharmaceuticals | 592.90M |
| Vectorite Biomedical | 547.14M |
| LAUNXP Biomedical | 543.62M |